Coal India has secured a Rs 2,831 crore solar project order, while Hero MotoCorp unveiled a Rs 3,200 crore investment roadmap in Andhra Pradesh. Additionally, Lupin received key European regulatory approval for its drug NaMuscla, and Airtel Money officially commenced operations as an NBFC.
Coal India's Renewable Energy Push
Coal India Limited (CIL) has secured a significant order to develop a 600 MW solar power plant at the Jalaun Solar Park in Uttar Pradesh. The project, awarded by Bundelkhand Saur Urja Limited, is estimated to cost approximately Rs 2,831.11 crore. The contract requires the development of two 300 MW units at a tariff of Rs 2.73 per kWh. The project is expected to be completed within 18 months from the date of signing the Power Purchase Agreement. This development is part of Coal India's broader efforts to diversify its energy portfolio and transition toward sustainable energy sources.
Hero MotoCorp's Andhra Pradesh Expansion
Hero MotoCorp has laid the foundation stone for its second Global Parts Centre (GPC) in Tirupati, Andhra Pradesh, with an investment of over Rs 750 crore. This facility is a key component of the company's wider Rs 3,200 crore investment roadmap in the state, which aims to establish Tirupati as a central hub for global manufacturing, logistics, and electric mobility. The Tirupati site is set to play a critical role in managing Hero MotoCorp's electric vehicle (EV) portfolio, specifically the VIDA brand. The company intends to scale its local EV manufacturing and engineering capabilities, signaling a focus on long-term infrastructure and supply chain resilience.
Lupin's European Approval
Lupin Limited announced that the European Medicines Agency (EMA) has approved expanded marketing authorizations for its drug, NaMuscla. This approval includes new dosage strengths (62 mg and 83 mg capsules) and expands the indicated use to include pediatric patients (children aged 6–11 years) and adolescents alongside adults with non-dystrophic myotonic disorders. NaMuscla is an antimyotonic agent used to treat muscle stiffness and is a key product in Lupin's specialty pharmaceutical portfolio in Europe. This approval allows Lupin to address a wider patient base and improve dosing precision for younger populations.
Airtel Money Begins NBFC Operations
Bharti Airtel’s subsidiary, Airtel Money, has officially commenced commercial operations as a non-deposit accepting non-banking financial company (NBFC-ND-ICC). Following the receipt of its registration from the Reserve Bank of India (RBI) in February 2026, the company has confirmed plans to capitalize the entity with Rs 20,000 crore over the next few years. Bharti Airtel is set to contribute 70% of this capital, with the promoter group providing the remaining 30%. This transition enables Airtel to engage in regulated lending activities and expand its digital financial services ecosystem beyond its core telecommunications business.
What Investors Should Track Next
For Coal India, the monitorable will be the project execution timeline, especially given historical discussions regarding renewable project implementation. Regarding Hero MotoCorp, investors may track the progress of the Tirupati hub and its impact on the company's EV production capacity and margin performance. For Lupin, the focus will be on the rollout and market penetration of the newly approved dosage strengths in Europe. Finally, regarding Airtel Money, the key factor to watch is the scaling of the lending portfolio and how the new NBFC structure contributes to Bharti Airtel's financial performance in the coming quarters.